Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillationWinnie Chua, Larissa Fabritz, Dipak Kotecha et al.|European Heart Journal|2018Cited by 147
Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular DeathPaul Brady, Paulus Kirchhof, František Neháj et al.|Journal of the American Heart Association|2022Cited by 45
An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditionsWinnie Chua, Larissa Fabritz, Stéphane Hatem et al.|Scientific Reports|2023Cited by 28
Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation studyWinnie Chua, Larissa Fabritz, André Ziegler et al.|PLoS Medicine|2021Cited by 18
Detection of unknown atrial fibrillation by prolonged ECG monitoring in an all-comer patient cohort and association with clinical and Holter variablesMuhammad Jawad‐Ul‐Qamar, Paulus Kirchhof, Larissa Fabritz et al.|Open Heart|2020Cited by 12